Diagnostics

A new study confirms AI can detect major heart conditions from one brief ultrasound clip, empowering any clinician to perform life-saving cardiac screening.

Neurocrine Biosciences begins a Phase 2 trial for a new tardive dyskinesia drug, aiming to build on its market dominance and offer new hope for patients.

As consolidation reshapes healthcare, Integrated Dermatology's new CMO appointment signals a strategic move to blend clinical leadership with corporate growth.

A new FDA-cleared test detects RSV, Flu A/B, and COVID from a single swab, offering a powerful diagnostic tool for families, especially for infants.

A major clinical trial setback for a promising liver disease drug leaves patients waiting and puts Bausch Health's future strategy under scrutiny.

Acrivon Therapeutics to unveil pivotal data showing high response rates for its targeted drug ACR-368 in an aggressive endometrial cancer subtype.

Ozelle will debut an AI system at WHX Labs Dubai that merges three lab functions into one, promising faster, smarter diagnostics for local clinics.

As Embecta prepares its Q1 results, investors watch closely to see if its move beyond insulin can reverse recent revenue declines and reshape its future.

A new strategic partnership aims to dismantle commercialization hurdles, promising faster access to life-saving therapies for rare disease patients.

Canada aims to eliminate cervical cancer by 2040, but rising rates and lagging prevention efforts place the ambitious public health goal at a crossroads.

With demand soaring, diagnostics leader PreludeDx hires veteran MiMi Reyes to scale lab operations and spearhead the launch of its new AidaBreast test.

A new global consortium aims to break the antibiotic R&D logjam, using open science and AI to combat the growing superbug crisis threatening millions.

India's 'Vaccine Capital' unveils a bold new policy at Davos, shifting from manufacturing to high-value innovation to join the world's top life sciences hubs.

A unique partnership between the City of Philadelphia, the Eagles, and a nonprofit is creating new hope for thousands awaiting a life-saving kidney transplant.

Portable tissue oxygen monitors, forged in US military R&D, are now in Ukraine to help medics make life-or-limb decisions in real time.

A new, self-administered RNA therapy for hereditary angioedema gains EU approval, promising fewer attacks and greater freedom for thousands of patients.

As AI transforms medicine, Lunit engages global leaders at Davos to build trust and set ethical standards for its use in the fight against cancer.

A clinical trial for D-Serine begins in Norway, testing a novel approach that could finally slow or halt the progression of Parkinson's disease.

A breakthrough liquid biopsy using '6-base genome' analysis shows unprecedented success in spotting Stage I colorectal cancer, promising to boost survival rates.

Machina Medical's novel hydrogel barrier, MFUSE, gains FDA clearance, promising to control severe bleeding in seconds and disrupt the hemostasis market.